A

Agilent Technologies – A Snapshot of the Stock

Agilent Technologies shares fell by -2.2% during the day's afternoon session, and are now trading at a price of $132.36. Is it time to buy the dip? To better answer that question, it's essential to check if the market is valuing the company's shares fairly in terms of its earnings and equity levels.

Trades Below Its Graham Number but Has an Elevated P/B Ratio:

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company belongs to the Industrials sector, which has an average price to earnings (P/E) ratio of 22.19 and an average price to book (P/B) ratio of 4.06. In contrast, Agilent Technologies has a trailing 12 month P/E ratio of 31.5 and a P/B ratio of 6.62.

Agilent Technologies's PEG ratio is 2.59, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

Strong Revenue Growth and Healthy Leverage Levels:

2017 2018 2019 2020 2021 2022
Revenue (M) $4,472 $4,914 $5,163 $5,339 $6,319 $6,848
Operating Margins 18% 18% 18% 16% 21% 24%
Net Margins 15% 6% 21% 13% 19% 18%
Net Income (M) $684 $316 $1,071 $719 $1,210 $1,254
Net Interest Expense (M) $79 $75 $74 $78 $81 $84
Depreciation & Amort. (M) $212 $210 $238 $308 $321 $317
Diluted Shares (M) 326 325 318 312 307 300
Earnings Per Share $2.1 $0.97 $3.37 $2.3 $3.94 $4.18
EPS Growth n/a -53.81% 247.42% -31.75% 71.3% 6.09%
Avg. Price $62.24 $64.69 $73.1 $90.72 $142.77 $128.75
P/E Ratio 29.36 66.01 21.44 38.94 35.87 30.73
CAPEX (M) $176 $177 $155 $119 $188 $291
EV / EBITDA 19.06 18.09 20.1 24.92 26.6 20.59
Total Debt (M) $2,000 $1,792 $2,402 $2,359 $2,729 $2,769
Net Debt / EBITDA -0.67 -0.41 0.87 0.8 0.75 0.89
Current Ratio 3.3 3.33 1.53 2.33 2.22 2.03

Agilent Technologies benefits from rapidly growing revenues and increasing reinvestment in the business, strong operating margins with a positive growth rate, and an excellent current ratio of 2.03. The company's financial statements show a strong EPS growth trend and healthy leverage levels.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS